Lets talk
For Investors
We are a biotech company focused on developing breakthrough cancer therapies to improve patient outcomes and quality of life.
Promising Lead Compound
Demonstrated in vitro and in vivo efficacy against triple-negative breast cancer and prostate cancer with a favorable safety profile.
Learn more
Robust Pipeline
Over 15 preclinical compounds targeting a diverse range of cancers.
Click Here